← SynDRA
CARBIDOPA ANHYDROUS
SynDRA canonical compound SYN0023488 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DDC |
|---|
| Mechanism of action | Aromatic L-amino acid decarboxylase inhibitor |
|---|
| Indication | Parkinson's Disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Aromatic L-amino acid decarboxylase inhibitor
- DDC INHIBITOR
- DOPA decarboxylase inhibitor
Drug classes
- Anti-Dyskinesia Agents
- Antiparkinson Agents
- Aromatic Amino Acid Decarboxylase Inhibitors
- Central Nervous System Agents
- Dopamine Agents
- Enzyme Inhibitors
- Neurotransmitter Agents
- Aromatic Amino Acid Decarboxylation Inhibitor
- DOPA Decarboxylase Inhibitors
Cross-references
Synonyms
- carbidopa
- carbidopa hydrate
- lodosin
- (S)-Carbidopa
- lodosyn
- alpha-Methyldopahydrazine
- Carbidopa, l- anhydrous
- Lodosyn
- MK-486
- DUOPA COMPONENT CARBIDOPA
- carbidopa (ep monograph)
- LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT CARBIDOPA
- Carbidopa hydrate
- DHIVY COMPONENT CARBIDOPA
- carbidopa (usp-rs)
- Carbidopa monohydrate
- CARBIDOPA
- CORBILTA COMPONENT CARBIDOPA
- KR87B45RGH
- NSC 758190
- RYTARY COMPONENT CARBIDOPA
- PARCOPA COMPONENT CARBIDOPA
- IPX-203 COMPONENT CARBIDOPA
- Carbidopum monohydrate
- MNX7R8C5VO
- SINEMET COMPONENT CARBIDOPA
- DOPASNAP COMPONENT CARBIDOPA
- CARBIDOPA, L- ANHYDROUS
- STALEVO COMPONENT CARBIDOPA
- carbidopa (usp monograph)
- CARBILEV COMPONENT CARBIDOPA
- CREXONT COMPONENT CARBIDOPA
- NSC 751137
- (S)-carbidopa
- (S)-(-)-carbidopa
- N-Aminomethyldopa
- Carbidopum
- L-alpha-Methyldopahydrazine
- Carbidopa (anhydrous)
Reported adverse events
- Hypersensitivity
- Rash
- Angioedema
- Ataxia
- Gastrointestinal pain
- Henoch-Schonlein purpura
- Constipation
- Dyskinesia
- Nausea
- Depression
- Asthenia
- Dizziness
Look up CARBIDOPA ANHYDROUS in the interactive SynDRA portal →